New study on Omniactive’s Capsimax reafirms weight management support benefit through increased metabolic rate

Mumbai, India and Morristown, N.J., April 6, 2021 — OmniActive Health Technologies (OmniActive) announced today outcomes of a new study on Capsimax, showing significant increases in resting energy expenditure (REE) post consumption of Capsimax. The findings from this randomized, double-blind, placebo-controlled metabolic rate study that involved 28 healthy adults was presented at the Global Summit on Obesity, Diet and Nutrition and published in the Journal of Obesity and Therapeutics.

REE represents the amount of energy expended by a person at rest to maintain the basic and vital functions of the body and accounts for up to 70% of total energy expenditure. Increases in energy expenditure have been linked to reduction in body fat. Our findings specific to increases in REE are consistent with our previously published study showing similar benefits of Capsimax, an encapsulated, concentrated extract of capsaicinoids from red chili peppers (Capsicum annum). In our first metabolic rate study, Capsimax demonstrated that it increased metabolic rate in individuals during fed conditions, while this new study measured the benefits of participants during fasting conditions.

“The primary objective was to measure changes in REE from baseline to post treatment at 1, 2, 3 and 4 hours in comparison to placebo,” explained Deshanie Rai, Ph.D., Vice President, Global Scientific and Regulatory Affairs. “We observed robust and significant changes in REE with Capsimax supplementation during the first 3 hours of the study vs. the placebo group.”

“These findings are consistent with our earlier published clinical results demonstrating a benefit of Capsimax on increased metabolic rate and adds another layer of substantiation that should help consumers feel confident that Capsimax is effective either with or without a meal,” Dr. Rai said.

Perceived changes in body temperature in response to Capsimax supplementation was also measured in the study. Dr. Rai continued by saying, “Similar to previous findings, study participants reported an increased feeling of warmth with Capsimax supporting an “experiential benefit.” These results reaffirm Capsimax’s efficacy for weight management support, sports nutrition, and beyond.

 

Media contacts

 

Sabrina Di Blasio
OmniActive
+1 514-258-8183
sabrina@omniactives.com

 

Becky Wright
Wright On Marketing & Communications
+1 201-675-0197
becky@wrightonmarketing.com

 

About OmniActive

OmniActive Health Technologies offers scientifically validated, sustainable, IP-protected, health benefit solutions from natural sources for customers in the dietary supplement and functional food and beverage space. OmniActive’s mission is improving lives through enhancing nutrition through branded health benefit solutions that consumers demand in top categories such as: Active Wellness & Physical Performance; Metabolic Health & Weight Wellness; Vision, Cognition & Mental Wellness; Daily Energy and Productivity Performance; and Digestion & Immune Health. Some of its leading brands include Lutemax® 2020 in the eye health market, Capsimax® in the weight management market, CurcuWIN® in the sports nutrition and active lifestyle market, Gingever for digestion and immune health, and enXtra® and Xtenergy™ in the daily energy categories. Lutemax® and CurcuWIN® are also USP certified and Non-GMO Project Verified.

With an established production, sales and distribution network in Asia, Europe, North America and South America, OmniActive is well-positioned to understand the unique needs and regulatory landscapes of each market. Currently, it has manufacturing plants across India, specifically in Pune, Bengaluru and Hosur, which are FDA GMP compliant. It also maintains head offices in Mumbai, India, as well as Morristown, New Jersey. For more information, visit www.omniactives.com.